Demonstrating Feasibility of Using a Robot to Deliver a Multicomponent Intervention to Reduce Delirium Occurrence in Hospitalized Elderly Subjects at Risk of Delirium (temidelirium)

November 15, 2026 updated by: Vigorous Mind, Inc.

This is a feasibility study. 20 non-ICU hospitalized patients at high risk of getting delirium will be consented and screened to receive a personalized multicomponent non-pharmacological intervention through an autonomous navigating robot at the bedside.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria: High risk of delirium: Agr >80, dementia, High readmission risk score as calculated by EPIC, postoperative

Exclusion Criteria: Patients who screen positive for delirium by CAM Patients who are actively dying Patients who cannot perform the CAM due to language or advanced dementia or level of consciousness

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: patients at high risk of delirium who meet the inclusion criteria

Feasibility study of using an autonomous mobile robot to deliver a personalized multicomponent non-pharmacological intervention to prevent delirium at the bedside

personalized multicomponent non-pharmacological intervention through an autonomous mobile robot to prevent delirium

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Robot correctly arrived at the bedside and greeted the patient
Time Frame: Two months of feasibility study

The robot has to navigate to the bedside of each patient at a scheduled time

Two months of feasibility study
Robot correctly arrived at the bedside, oriented the patient and delivered the personalized multicomponent non-pharmacological intervention.
Time Frame: Two months of the feasibility study

The robot has to identify the patient, get permission to talk to the patient and then deliver the orientation and engage the patient in a series of activities if the patient agrees.

Two months of the feasibility study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 16, 2026

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

April 30, 2027

Study Registration Dates

First Submitted

November 15, 2026

First Submitted That Met QC Criteria

November 15, 2026

First Posted (Actual)

November 20, 2026

Study Record Updates

Last Update Posted (Actual)

November 20, 2026

Last Update Submitted That Met QC Criteria

November 15, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • BUH3-2399997
  • 1R43AG094367-01 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.